| Ticker Details |
Ascendis Pharma A/S
Ascendis Pharma A/S is a biotechnology company that applies its TransCon technology to develop a pipeline of prodrug therapies with profiles that address markets with unmet medical needs.
|
| IPO Date: |
July 11, 2008 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$16.61B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.06 | 2.03%
|
| Avg Daily Range (30 D): |
$3.77 | 1.46%
|
| Avg Daily Range (90 D): |
$4.57 | 1.90%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.28M |
| Avg Daily Volume (30 D): |
.42M |
| Avg Daily Volume (90 D): |
.55M |
| Trade Size |
| Avg Trade Size (Sh.): |
64 |
| Avg Trade Size (Sh.) (30 D): |
40 |
| Avg Trade Size (Sh.) (90 D): |
48 |
| Institutional Trades |
| Total Institutional Trades: |
4,400 |
| Avg Institutional Trade: |
$4.41M |
| Avg Institutional Trade (30 D): |
$10.68M |
| Avg Institutional Trade (90 D): |
$13.78M |
| Avg Institutional Trade Volume: |
.03M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.43M |
| Avg Closing Trade (30 D): |
$13.73M |
| Avg Closing Trade (90 D): |
$20.71M |
| Avg Closing Volume: |
31.75K |
|
|
|
|
|
